Zobrazeno 1 - 10 of 20 pro vyhledávání: '"Kerem Ozcan"'
7
Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities
Autor: Tao Wang, Gokce Askan, Kerem Ozcan, Satshil Rana, Ahmet Zehir, Umeshkumar K. Bhanot, Rhonda K. Yantiss, Deepthi S. Rao, Samuel J. Wahl, Pelin Bagci, Serdar Balci, Vinod Balachandran, William R. Jarnagin, N. Volkan Adsay, David S. Klimstra, Olca Basturk
Publikováno v: Archives of Pathology & Laboratory Medicine.
Context.— Tumoral (grossly visible) intraductal neoplasms of the bile ducts are still being characterized. Objective.— To investigate their morphologic, immunohistochemical, and molecular features. Design.— Forty-one cases were classified as ga
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89a3d57abb8ab22c7bd9a7cc7c4329cc
https://doi.org/10.5858/arpa.2022-0343-oa
Zobrazit plný text záznamu
8
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
Autor: Nicolas A. Giraldo, Esther Drill, Baby A. Satravada, Imane El Dika, A. Rose Brannon, Josephine Dermawan, Abhinita Mohanty, Kerem Ozcan, Debyani Chakravarty, Ryma Benayed, Efsevia Vakiani, Ghassan K. Abou-Alfa, Ritika Kundra, Nikolaus Schultz, Bob T. Li, Michael F. Berger, James J. Harding, Marc Ladanyi, Eileen M. O'Reilly, William Jarnagin, Chad Vanderbilt, Olca Basturk, Maria E. Arcila
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research.
Purpose: Gallbladder carcinoma (GBC) is an uncommon and aggressive disease, which remains poorly defined at a molecular level. Here, we aimed to characterize the molecular landscape of GBC and identify markers with potential prognostic and therapeuti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc2091e4db77a4327f9abb8d49daeb1e
https://pubmed.ncbi.nlm.nih.gov/36228155
Zobrazit plný text záznamu
9
A clinicopathological experience in acute myeloid leukemia: Effects of clinical data and status of FLT3, CEBPA and NPM1 on prognosis
Autor: Emre, Yener, Kerem, Ozcan, Şeniz, Öngören, Ayşe, Salihoğlu, Ahu Senem, Demiröz, Hilal, Akı
Publikováno v: Indian journal of pathologymicrobiology. 65(3)
The purpose of the study was to analyze the expression of nucleophosmin (NPM1), CCAT/enhancer-binding protein alpha (CEBPA), and FMS-like tyrosine kinase 3 (FLT3) with immunohistochemistry and evaluate the relationship with clinicopathologic data wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::abc2bc92d3cdd0d3efea3ad2fe3c1f07
https://pubmed.ncbi.nlm.nih.gov/35900493
Zobrazit plný text záznamu
10
Pancreatoblastomas and Mixed and Pure Acinar Cell Carcinomas Share Epigenetic Signatures Distinct from Other Neoplasms of the Pancreas
Autor: Jamal K. Benhamida, Monika Vyas, Atsushi Tanaka, Lu Wang, Armita Bahrami, Kerem Ozcan, Olca Basturk, Liliana Villafania, Douglas A. Mata, Tony El Jabbour, Pier Selenica, M.H.A. Roehrl, Britta Weigelt, Jorge S. Reis-Filho, Maurizio Scaltriti, David S. Klimstra
Publikováno v: Mod Pathol
Pancreatic neoplasms are heterogenous and have traditionally been classified by assessing their lines of cellular differentiation using histopathologic methods, particularly morphologic and immunohistochemical evaluation. These methods frequently ide
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea4010e53f82b4020694f01eef4f7dc
https://europepmc.org/articles/PMC10319432/
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje